Supplementation With Spirulina Reduces Infarct Size and Ameliorates Cardiac Function in a Pig Model of STEMI

Background and Aims: Myocardial infarction (MI) is the clinical manifestation of atherosclerotic coronary artery disease. Spirulina is an algae known to ameliorate cardiometabolic disorders and with proven anti-inflammatory and anti-oxidant effects. We investigated, in a highly translatable animal m...

Descripción completa

Detalles Bibliográficos
Autores principales: Vilahur, Gemma, Sutelman, Pablo, Ben-Aicha, Soumaya, Mendieta, Guiomar, Radiké, Monika, Schoch, Leonie, Casaní, Laura, Borrell-Pagés, María, Padro, Teresa, Badimon, Lina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113432/
https://www.ncbi.nlm.nih.gov/pubmed/35592428
http://dx.doi.org/10.3389/fphar.2022.891801

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113432/
https://www.ncbi.nlm.nih.gov/pubmed/35592428
http://dx.doi.org/10.3389/fphar.2022.891801

Ejemplares similares